000			01992nam a2200325 4500
003			VRT
005			20241105235303.0
008			091109| xx |||||||||||0||||| |d
020	0	0	_a0-85199-617-5
035			_a20023189371
039		9	_y200911092043 _zamirul _w301-400 300909.mrc _x2
040	0	0	_aCABI _cCABI
100	1	0	_aVercruysse, J.
245	1	0	_aMacrocyclic lactones in antiparasitic therapy
260	0	0	_aWallingford _b:CAB International _c:2002
300	0	0	_axiv + 432 .
520	3	0	_aThis book contains 14 chapters on macrocyclic lactones (MLs). Chapter 1 covers chemistry, pharmacology and drug safety and chapter 2 deals with pharmacokinetics. New information on the mode of action emphasizing glutamate-gated chloride ion channels are reviewed in chapter 3. The impact of MLs on dung fauna is described in chapter 4. Chapter 5 reviews resistance mechanisms and field resistance. The use of MLs to control parasites of cattle is discussed in several sections in chapter 6. The next seven chapters deal with ML use in sheep and goats, horses, pigs, dogs and cats, wild ruminants, exotic pets and man, respectively. Finally, chapter 14 examines scientific, social, political and economic issues that control the future of MLs. The likely readership is composed of researchers and veterinarians.
650	0	4	_aHH405 - Pesticides and Drugs; Control, (New March 2000)
650	0	4	_aHH410 - Pesticide and Drug Resistance
650	0	4	_aLL822 - Protozoan, Helminth, Mollusc and Arthropod Parasites of Animals, (New March 2000)
650	0	4	_aLL882 - Veterinary Pharmacology and Anaesthesiology, (New March 2000)
650	0	4	_aVV220 - Protozoan, Helminth and Arthropod Parasites of Humans, (New March 2000)
700	1	0	_aRew, R. S.
700	1	0	_aRew, R. S.
700	1	0	_aVercruysse, J.
856	4	0	_uhttp://dx.doi.org/10.1079/9780851996172.000
907			_a.b10358481 _b05-12-17 _c05-12-17
910			_avtls000036399
998			_anone _b - - _cm _da _e- _f _gxx _h0
999			_c35726 _d35726